)
Visual24 Oct 2025
The rise of Alphabet
Diaceutics (DXRX) investor relations material
Diaceutics H1 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2025 earnings summary23 Sep, 2025
Executive summary
Revenue grew 22% on a constant currency basis to £14.6m in H1 2025, with a 3-year CAGR of 25%.
Adjusted EBITDA reached £0.1m, rebounding from a loss of £0.9m in H1 2024, signaling a shift toward profitability.
Order book stands at £31.7m, with £9.0m contracted for H2 2025 delivery.
Annual Recurring Revenue (ARR) increased 16% to £16.4m, now representing 61% of total H1 revenues.
Strong commercial momentum, US expansion, and significant technical upgrades to the DXRX platform, including advanced AI integration.
Financial highlights
Revenue for H1 2025 was £14.6m, up 22% on a constant currency basis and 18% year-over-year.
Gross profit rose 13% to £12.1m, with gross margin at 83% (down from 87% in H1 2024, stable at 86% constant currency).
Adjusted EBITDA improved to £0.1m from a loss of £0.9m in H1 2024.
Cash and equivalents at £10.4m, with no debt, supporting organic growth.
Order book value increased to £31.7m from £27.9m at June 2024.
Outlook and guidance
On track to deliver full-year profitability in FY 2025, with continued focus on recurring revenue and operational leverage.
Board reaffirms confidence in meeting 2025 profitability targets and trading in line with expectations.
H2 expected to be stronger due to industry spending patterns, with a similar revenue split as 2024 (38:62 H1:H2).
Preparing to launch new market reach initiatives in 2025, targeting broader diagnostic-enabled therapies.
Targeting a 25% CAGR for revenue and ARR.
How does expensing AI/platform costs impact financials?
Strategy for capturing expanded precision medicine TAM?
H2 cash conversion strategy to maintain neutrality?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Diaceutics earnings date
H2 202512 May, 2026
Next Diaceutics earnings date
H2 202512 May, 2026
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Diaceutics PLC specializes in providing comprehensive solutions for the commercialization of precision medicine. Diaceutics integrates multiple pipelines of real-world, real-time diagnostic testing data from a global network of laboratories. Diaceutics PLC is headquartered in the United Kingdom, and its shares are listed on the London Stock Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage